Investigation of treatment expectancy in patients with atopic dermatitis undergoing a modern system therapy
- Conditions
- L20Atopic dermatitis
- Registration Number
- DRKS00032191
- Lead Sponsor
- niversitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Patients with atopic dermatitis and indication for initiation of systemic therapy.
- Women of childbearing potential with contraception (according to the Standard of Care)
- Pregnancy and breast-feeding; lack of willingness to use effective contraception.
- Insufficient ability to communicate in the German language or lack of understanding of the German language; dementia or (functional) illiteracy.
- Lacking or absent capacity of the patient to give consent
- Presence of contraindications to systemic therapy with an IL-4 and IL-13 blocker or a JAK inhibitor.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Subjective pror experiences, expectations as well as perception of warmth and competence at the beginning and during the course of therapy<br>- Correlation of recorded psychological factors and skin symptoms before and during therapy<br>- Correlation of recorded psychological factors and perceived treatment success<br>- Comparison of proinflammatory cytokines in blood serum (especially IL-4, IL-5, IL-13, IL-31) and serum cortisol before the start of therapy and 16 weeks after therapy initiation
- Secondary Outcome Measures
Name Time Method - Association of recorded psychological factors and therapy success with the level of proinflammatory cytokines and serum cortisol.<br>- Associations of psychological factors prior experience, expectancy, and perceptions of warmth and competence with each other<br>- Correlations of proinflammatory cytokine activity with plasma cortisol activity